Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access |
Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc |
Journal website http://www.jofem.org |
Original Article
Volume 4, Number 5-6, December 2014, pages 121-135
Associations Between Liver Function, Bone Turnover Biomarkers and Adipokines in Older Patients With Hip Fracture
Figure
Tables
Clinical characteristic | Laboratory characteristic | ||
---|---|---|---|
CAD: coronary artery disease; TIA: transient ischemic attack; DM: diabetes mellitus; CKD: chronic kidney disease; COPD: chronic obstructive pulmonary disease; ALT: alanine aminotransferase; GGT: gamma-glutamyltransferase; ALP: alkaline phosphatase; 25(OH)D: 25-hydroxyvitamin D; PTH: parathyroid hormone; TSH: thyroid-stimulating hormone; T4: thyroxin; eGFR: estimated glomerular filtration rate; SHPT: secondary hyperparathyroidism (PTH > 6.8 pmol/L); NTx/Cr: cross-linked N-telopeptide of type 1 collagen corrected for urinary creatinine concentration; DPD/Cr: deoxypyridinoline corrected for urinary creatinine concentration. *Malnutrition was defined as serum leptin concentration < 4 ng/mL in males and < 6.5 ng/mL in females. **Vitamin D insufficiency was defined as 25(OH)D < 50 nmol/L. | |||
Age, years (mean ± SD) | 82.2 ± 7.9 | ALT, U/L | 23.0 ± 42.6 |
Females, % | 72.1 | GGT, U/L | 54.1 ± 95.6 |
Cervical/trochanteric fracture, n | 152/142 | ALP, U/L | 105.4 ± 80.1 |
Hypertension, % | 54.0 | Albumin, g/L | 37.1 ± 6.3 |
CAD, % | 21.2 | Bilirubin, µmol/L | 12.4 ± 7.4 |
Atrial fibrillation, % | 13.2 | OC, ng/mL | 17.2 ± 15.2 |
History of stroke or TIA, % | 21.7 | BAP, U/L | 26.4 ± 14.2 |
Type 2 DM, % | 18.8 | NTx/Cr, nmol/µmol | 159.4 ± 169.0 |
Dementia, % | 27.8 | DPD/Cr, nmol/µmol | 12.6 ± 7.2 |
Parkinson’s disease, % | 4.4 | 25(OH)D, nmol/L | 37.3 ± 18.0 |
COPD, % | 11.8 | PTH, pmol/L | 6.9 ± 5.6 |
CKD stage ≥ 3, % | 42.6 | Adiponectin, ng/mL | 17.5 ± 7.4 |
Malnutrition*, % | 33.8 | Leptin, ng/mL | 18.5 ± 23.2 |
Alcohol (≥ 3 times a week), % | 9.5 | Resistin, ng/mL | 18.7 ± 10.5 |
Ex-smokers, % | 10.0 | Hb, g/L | 124.9 ± 17.1 |
Current smokers, % | 5.4 | TSH, mU/L | 1.55 ± 2.17 |
Vitamin D insufficiency**, % | 79.7 | T4, pmol/L | 15.9 ± 3.54 |
SHPT, % | 38.2 | eGFR, mL/min/1.73 m2 | 65.1 ± 23.7 |
GGT | ALT | ALP | Albumin | Bilirubin | |
---|---|---|---|---|---|
Pearson’s correlation coefficients for log-transformed variables after adjustment for age and sex shown. GGT: gamma-glutamyltransferase; ALT: alanine aminotransferase; ALP: alkaline phosphatase; eGFR: estimated glomerular filtration rate; OC: osteocalcin; BAP: bone specific alkaline phosphatase; DPD/Cr: deoxypyridinoline corrected for urinary creatinine concentration; NTx/Cr: cross-linked N-telopeptide of type 1 collagen corrected for urinary creatinine concentration; 25(OH)D: 25-hydroxyvitamin D; PTH: parathyroid hormone; TSH: thyroid-stimulating hormone; T4: thyroxin; Cac: calcium corrected for albumin; PO4: phosphate; Mg: magnesium. *P < 0.05; **P < 0.001; ***P < 0.001. | |||||
OC | -0.182** | -0.158** | 0.104 | -0.034 | -0.147* |
BAP | 0.307*** | 0.050 | 0.462*** | 0.014 | 0.005 |
OC/BAP | -0.350*** | -0.178** | -0.183** | -0.035 | -0.137* |
DPD/Cr | 0.018 | -0.071 | 0.191** | -0.037 | -0.021 |
NTx/Cr | -0.134* | -0.041 | 0.150* | -0.069 | -0.035 |
25(OH)D | 0.014 | -0.022 | -0.165** | 0.012 | -0.021 |
PTH | 0.053 | 0.058 | 0.111 | 0.036 | 0.139* |
Cac | -0.002 | 0.086 | 0.133* | -0.111 | -0.039 |
PO4 | -0.016 | -0.049 | 0.092 | 0.058 | -0.075 |
Mg | -0.087 | -0.068 | 0.017 | 0.105 | -0.065 |
Leptin | -0.082 | -0.025 | -0.045 | 0.108 | -0.029 |
Adiponectin | 0.146* | 0.087 | 0.059 | 0.010 | 0.128* |
Resistin | 0.088 | 0.001 | 0.054 | 0.124* | 0.153* |
L/A | -0.116 | -0.070 | -0.044 | 0.109 | -0.055 |
L/R | -0.109 | -0.038 | -0.054 | 0.059 | -0.077 |
A/R | 0.022 | 0.053 | -0.011 | -0.090 | -0.034 |
TSH | 0.132* | 0.057 | -0.037 | -0.014 | 0.043 |
T4 | -0.186** | 0.121* | -0.144* | 0.027 | 0.007 |
Hb | -0.146* | 0.071 | -0.129* | 0.281*** | 0.047 |
Log GGT | Log ALT | Log ALP | Log albumin | Log bilirubin | ||||||
---|---|---|---|---|---|---|---|---|---|---|
A | B | A | B | A | B | A | B | A | B | |
β (P value) | β (P value) | β (P value) | β (P value) | β (P value) | β (P value) | β (P value) | β (P value) | β (P value) | β (P value) | |
Parameters identified as significant and independent predictors of GGT, ALT, albumin and bilirubin are shown. β: β-standardized regression coefficient; GGT: gamma-glutamyltransferase; ALT: alanine aminotransferase; ALP: alkaline phosphatase; OC: osteocalcin; BAP: bone specific alkaline phosphatase; DPD/Cr: deoxypyridinoline corrected for urinary creatinine concentration; NTx/Cr: cross-linked N-telopeptide of type 1 collagen corrected for urinary creatinine concentration; 25(OH)D: 25-hydroxyvitamin D; PTH: parathyroid hormone; CAD: coronary artery disease; AF: atrial fibrillation; PD: Parkinson’s disease; R2: adjusted R-squared. A, model 1: adjusted for age, sex, OC, BAP, NTx/Cr, DPD/Cr, 25(OH)D, PTH, leptin, adiponectin, resistin, TSH, T4 and hemoglobin. B, model 2: further adjusted for alcohol use ≥ 3 drinks/week (yes/no), presence of CAD (yes/no), hypertension (yes/no), AF (yes/no), type 2 diabetes mellitus (yes/no), PD (yes/no) and chronic kidney disease (estimated glomerular filtration rate < 60 mL/min/1.73 m2, yes/no). | ||||||||||
Age | -0.012 (0.017) | |||||||||
Sex (m) | 0.264 (0.027) | 0.180 (0.026) | ||||||||
Log OC | -0.219 (0.011) | -0.176 (0.029) | -0.145 (0.016) | -0.155 (0.006) | -0.109 (0.025) | |||||
Log BAP | 0.595 (< 0.001) | 0.570 (< 0.001) | 0.490 (< 0.001) | 0.496 (< 0.001) | ||||||
Log NTx/Cr | -0.185 (0.002) | -0.172 (0.005) | ||||||||
Log 25(OH)D | -0.134 (0.015) | -0.131 (0.017) | ||||||||
Log PTH | 0.103 (0.038) | |||||||||
Log Hb | -0.897 (0.013) | 0.393 (< 0.001) | 0.390 (< 0.001) | |||||||
Log adiponectin | 0.228 (0.037) | 0.215 (0.050) | 0.130 (0.054) | |||||||
Log resistin | 0.043 (0.026) | 0.439 (0.023) | 0.119 (0.038) | |||||||
Alcohol + | 0.883 (< 0.001) | |||||||||
CAD | 0.309 (0.023) | |||||||||
AF | 0.405 (< 0.001) | |||||||||
PD | -0.516 (0.007) | |||||||||
R2 | 0.2500 | 0.2701 | 0.0497 | 0.0784 | 0.2380 | 0.2334 | 0.1104 | 0.1177 | 0.0678 | 0.1328 |
Log OC | Log BAP | Log NTx/Cr | Log DPD/Cr | OC/BAP ratio | |
---|---|---|---|---|---|
β (P value) | β (P value) | β (P value) | β (P value) | β (P value) | |
Parameters identified as significant and independent predictors of each bone turnover marker are shown. Adjusted for age, sex, GGT, ALT, ALP, albumin, bilirubin, 25(OH)D, PTH, leptin, adiponectin and resistin (all variables were log-transformed). β: β-standardized regression coefficient; GGT: gamma-glutamyltransferase; ALT: alanine aminotransferase; ALP: alkaline phosphatase; OC: osteocalcin; BAP: bone specific alkaline phosphatase; NTx/Cr: cross-linked N-telopeptide of type 1 collagen corrected for urinary creatinine concentration; DPD/Cr: deoxypyridinoline corrected for urinary creatinine concentration. | |||||
Age | 0.017 (0.001) | 0.033 (< 0.001) | |||
Log GGT | -0.141 (0.012) | 0.111 (0.003) | -0.315 (< 0.001) | -0.113 (0.043) | |
Log ALT | -0.132 (0.049) | ||||
Log ALP | 0.175 (0.038) | 0.246 (< 0.001) | 0.362 (0.008) | 0.208 (0.008) | |
Log leptin | 0.084 (0.014) | -0.118 (0.027) | -0.069 (0.075) | 0.013 (0.032) | |
R2 | 0.1498 | 0.2043 | 0.2225 | 0.1350 | 0.1155 |
Adjustments | OC < 14 ng/mL | BAP > 43 U/L | OC/BAP ratio < 0.6 | ||||||
---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | P value | OR | 95% CI | P value | OR | 95% CI | P value | |
GGT: gamma-glutamyltransferase (> 20 U/L, above the level in the first tertile); OC: osteocalcin; BAP: bone specific alkaline phosphatase; CAD: coronary artery disease; DM: diabetes mellitus. *Three or more times a week. +Adjustments for all covariates in the above model. **Adipokines: adiponectin, leptin, resistin. | |||||||||
Unadjusted | 2.26 | 1.32 - 3.87 | 0.003 | 4.76 | 1.03 - 30.33 | 0.044 | 2.62 | 1.52 - 4.54 | 0.001 |
+Age, sex | 2.06 | 1.23 - 3.46 | 0.006 | 4.42 | 0.99 - 19.68 | 0.051 | 2.68 | 1.58 - 4.54 | < 0.001 |
+Alcohol use* | 2.07 | 1.22 - 3.50 | 0.007 | 4.88 | 1.10 - 21.75 | 0.038 | 2.81 | 1.64 - 4.82 | < 0.001 |
+CAD | 2.10 | 1.23 - 3.57 | 0.006 | 5.05 | 1.38 - 22.66 | 0.035 | 2.79 | 1.65 - 4.79 | < 0.001 |
+DM | 2.07 | 1.22 - 3.53 | 0.007 | 4.81 | 1.06 - 21.73 | 0.041 | 2.70 | 1.57 - 4.66 | < 0.001 |
+Adipokines** | 2.20 | 1.22 - 3.94 | 0.008 | 7.55 | 0.99 - 60.32 | 0.053 | 2.29 | 1.28 - 4.12 | 0.005 |